| Product Code: ETC10602414 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Ireland continued to import Human Papilloma Virus products mainly from the USA, UK, Germany, Metropolitan France, and Serbia. The market showed a high concentration with the Herfindahl-Hirschman Index (HHI) remaining elevated. However, the compound annual growth rate (CAGR) from 2020 to 2024 was negative at -4.18%, indicating a challenging market environment. The growth rate dropped significantly from 2023 to 2024 by -30.16%, suggesting a potential decline in demand or other market factors affecting the import of HPV-related products into Ireland.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Human Papilloma Virus Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Human Papilloma Virus Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Human Papilloma Virus Market - Industry Life Cycle |
3.4 Ireland Human Papilloma Virus Market - Porter's Five Forces |
3.5 Ireland Human Papilloma Virus Market Revenues & Volume Share, By Virus Type, 2021 & 2031F |
3.6 Ireland Human Papilloma Virus Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.7 Ireland Human Papilloma Virus Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.8 Ireland Human Papilloma Virus Market Revenues & Volume Share, By Target Population, 2021 & 2031F |
3.9 Ireland Human Papilloma Virus Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Ireland Human Papilloma Virus Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination for preventing HPV-related diseases |
4.2.2 Government initiatives to promote HPV vaccination programs |
4.2.3 Growing prevalence of HPV infections and related diseases in Ireland |
4.3 Market Restraints |
4.3.1 High cost associated with HPV vaccines and screening tests |
4.3.2 Limited access to healthcare services in certain regions of Ireland |
4.3.3 Stigma and misconceptions surrounding HPV vaccination |
5 Ireland Human Papilloma Virus Market Trends |
6 Ireland Human Papilloma Virus Market, By Types |
6.1 Ireland Human Papilloma Virus Market, By Virus Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Human Papilloma Virus Market Revenues & Volume, By Virus Type, 2021 - 2031F |
6.1.3 Ireland Human Papilloma Virus Market Revenues & Volume, By HPV 16 & 18, 2021 - 2031F |
6.1.4 Ireland Human Papilloma Virus Market Revenues & Volume, By Low-Risk HPV Strains, 2021 - 2031F |
6.2 Ireland Human Papilloma Virus Market, By Vaccine Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Human Papilloma Virus Market Revenues & Volume, By Preventative Vaccine, 2021 - 2031F |
6.2.3 Ireland Human Papilloma Virus Market Revenues & Volume, By Therapeutic Vaccine, 2021 - 2031F |
6.3 Ireland Human Papilloma Virus Market, By Application Area |
6.3.1 Overview and Analysis |
6.3.2 Ireland Human Papilloma Virus Market Revenues & Volume, By Preventative Vaccination, 2021 - 2031F |
6.3.3 Ireland Human Papilloma Virus Market Revenues & Volume, By Cancer Prevention, 2021 - 2031F |
6.4 Ireland Human Papilloma Virus Market, By Target Population |
6.4.1 Overview and Analysis |
6.4.2 Ireland Human Papilloma Virus Market Revenues & Volume, By Teenagers, Young Adults, 2021 - 2031F |
6.4.3 Ireland Human Papilloma Virus Market Revenues & Volume, By High-Risk Individuals, 2021 - 2031F |
6.5 Ireland Human Papilloma Virus Market, By End Use |
6.5.1 Overview and Analysis |
6.5.2 Ireland Human Papilloma Virus Market Revenues & Volume, By Cervical Cancer Prevention, 2021 - 2031F |
6.5.3 Ireland Human Papilloma Virus Market Revenues & Volume, By Oncology Care, 2021 - 2031F |
7 Ireland Human Papilloma Virus Market Import-Export Trade Statistics |
7.1 Ireland Human Papilloma Virus Market Export to Major Countries |
7.2 Ireland Human Papilloma Virus Market Imports from Major Countries |
8 Ireland Human Papilloma Virus Market Key Performance Indicators |
8.1 Number of individuals vaccinated against HPV |
8.2 Rate of HPV-related diseases in Ireland |
8.3 Percentage of healthcare professionals recommending HPV vaccination |
8.4 Level of government funding allocated to HPV vaccination programs |
8.5 Public awareness and knowledge about HPV and its prevention |
9 Ireland Human Papilloma Virus Market - Opportunity Assessment |
9.1 Ireland Human Papilloma Virus Market Opportunity Assessment, By Virus Type, 2021 & 2031F |
9.2 Ireland Human Papilloma Virus Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.3 Ireland Human Papilloma Virus Market Opportunity Assessment, By Application Area, 2021 & 2031F |
9.4 Ireland Human Papilloma Virus Market Opportunity Assessment, By Target Population, 2021 & 2031F |
9.5 Ireland Human Papilloma Virus Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Ireland Human Papilloma Virus Market - Competitive Landscape |
10.1 Ireland Human Papilloma Virus Market Revenue Share, By Companies, 2024 |
10.2 Ireland Human Papilloma Virus Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |